ArticleAlzheimer's & dementia (New York, N. Y.)2020

Safety and tolerability of GRF6019 in mild-to-moderate Alzheimer's disease dementia.

Jonas Hannestad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.